Flynn Daniel Lee

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Flynn Daniel Lee's trades of Deciphera Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-21 2023-06-16
S Sale
45,129 +45.9%
320.80
US$1,452,964 		45,129 +45.9% 320.80 US$1,452,964
2023-02-17 2023-02-16
S Sale
7,479 +10.9%
164.09
US$1,757,665 		7,479 +10.9% 164.09 US$1,757,665
2023-01-19 2023-01-17
S Sale
71,245 -15.5%
199.51
US$1,829,521 		71,245 -15.5% 199.51 US$1,829,521
2022-06-21 2022-06-16
S Sale
1,768 -3.7%
10.75
US$19,006 		1,768 -3.7% 10.75 US$19,006
2022-02-18 2022-02-16
S Sale
1,366 -2.8%
9.05
US$12,362 		1,366 -2.8% 9.05 US$12,362
2021-02-18 2021-02-16
S Sale
508 -7.2%
48.87
US$24,826 		508 -7.2% 48.87 US$24,826
2019-10-30 2019-10-28
PlS Planned sale
29,820 -54.9%
40.00
US$1,192,800 		29,820 -54.9% 40.00 US$1,192,800
2019-01-18 2019-01-16
PlS Planned sale
152,629 -100.0%
26.00
US$3,968,354 		152,629 -100.0% 26.00 US$3,968,354
2019-01-15 2019-01-11
PlS Planned sale
300 -100.0%
26.00
US$7,800 		300 -100.0% 26.00 US$7,800